LYG:NYSELloyds Banking Group Plc Analysis
Data as of 2026-06-09 - not real-time
$5.26
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Lloyds Banking Group (LYG) is trading around $5.26, just above its near‑term support of $5.03 and below the $5.54 resistance level, with the 20‑day SMA (5.33) slightly under the 50‑day SMA (5.35) and a neutral RSI at 45, suggesting limited short‑term momentum. Technical indicators such as a bearish MACD histogram and a neutral trend direction reinforce a cautious outlook, while the stock’s 30‑day volatility of over 33% and a beta above 1.2 indicate heightened price swings. On the fundamentals side, the stock appears undervalued – its trailing P/E of 12.8 is well below the industry average of 16.5 and the forward P/E of 9.9 signals further upside, complemented by a solid dividend yield of 3.77% with a payout ratio under 45%, which supports dividend sustainability. Recent earnings were strong, with Q1 profit up 37% YoY and revenue growth of 11.5%, prompting UBS and Citi to upgrade the rating to Buy and lift price targets to around $6.00, implying roughly a 12% upside from current levels. The combination of attractive valuation, robust earnings momentum, and a generous dividend makes LYG a compelling value‑oriented play, though investors should remain mindful of the stock’s elevated volatility, regulatory exposure in the UK banking sector, and currency considerations.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bearish MACD and neutral RSI suggest limited upside in the near term
- Recent earnings beat and analyst upgrades provide support
- Dividend yield of 3.77% offers income while price hovers near support
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued valuation multiples relative to peers
- Strong revenue and profit growth driving earnings momentum
- Attractive dividend yield with sustainable payout ratio
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Stable banking franchise with consistent cash generation
- Regulatory and macro‑economic headwinds temper growth expectations
- Continued dividend income supports total return over time
Key Metrics & Analysis
Financial Health
Revenue Growth11.50%
Profit Margin26.50%
P/E Ratio12.8
ROE10.78%
ROA0.55%
P/B Ratio1.2
Industry P/E16.5
Technical Analysis
TrendNeutral
RSI45.2
Support$5.03
Resistance$5.54
MA 20$5.33
MA 50$5.35
MA 200$5.12
MACDBearish
VolumeStable
Fear & Greed Index84.04
Valuation
Target Price$5.92
Upside/Downside12.65%
GradeUndervalued
TypeBlend
Dividend Yield3.77%
Risk Assessment
Beta1.31
Volatility33.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.